Analystreport

Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating.

IMPRIMIS PHARMACEUTICALS  (IMMY) 
Last imprimis pharmaceuticals earnings: 5/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: imprimisrx.com